The technology and use of blastomere analysis

Area of Science:

• Reproductive medicine
• Genetics
• Embryology

Background:

• In vitro fertilization (IVF) is a common procedure for infertility treatment.
• Genetic abnormalities in embryos can lead to implantation failure or serious congenital diseases.
• Preimplantation genetic diagnosis (PGD) aims to improve IVF success rates and prevent genetic disorders.

Purpose of the Study:

• To describe the technique of blastomere analysis.
• To outline the current and potential applications of blastomere analysis in reproductive medicine.
• To identify implications for nursing practice and education regarding blastomere analysis.

Main Methods:

• Blastomere analysis involves the removal and genetic testing of one or more blastomeres from an early-stage embryo.
• Techniques may include polymerase chain reaction (PCR)-based methods for specific gene analysis or chromosomal aneuploidy screening.
• The analysis provides genetic information about the embryo's composition before implantation.

Main Results:

• Blastomere analysis enables the screening of embryos for serious genetic diseases prior to IVF.
• The technique offers valuable insights into an embryo's genetic makeup before the implantation stage.
• Current and future uses of blastomere analysis are discussed, highlighting its role in personalized reproductive care.

Conclusions:

• Blastomere analysis is a valuable tool for genetic screening in assisted reproductive technologies.
• It has significant implications for preventing the transmission of serious genetic disorders.
• Understanding and implementing blastomere analysis is crucial for healthcare professionals, including nurses, involved in IVF.